Click for best price
Gastrointestinal Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 32740 million
|
Forecast Market size by 2030 |
US$ 41410 million
|
| Growth Rate |
CAGR of 3.4% |
Number of Pages |
115 Pages |
This research report provides a comprehensive analysis of the Gastrointestinal Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Gastrointestinal Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Gastrointestinal Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Gastrointestinal Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Gastrointestinal Drugs market presents opportunities for various stakeholders, including Chronic Gastritis, Functional Dyspepsia. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Gastrointestinal Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Gastrointestinal Drugs market was valued at US$ 32740 million in 2023 and is projected to reach US$ 41410 million by 2030, at a CAGR of 3.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Gastrointestinal Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Gastrointestinal Drugs market.
Market Overview: The report provides a comprehensive overview of the Gastrointestinal Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Gastrointestinal Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Gastrointestinal Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Gastrointestinal Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Gastrointestinal Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Gastrointestinal Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Gastrointestinal Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Gastrointestinal Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Gastrointestinal Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Gastrointestinal Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Prescription Gastrointestinal Drug
- OTC Gastrointestinal Drug
Market segment by Application
- Chronic Gastritis
- Functional Dyspepsia
- Peptic Ulcer
- Acute Gastroenteritis
- Other
Global Gastrointestinal Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- AstraZeneca
- Sanofi
- Bayer
- Pfizer
- GlaxoSmithKline
- Teva
- Zeria (Tillotts)
- Perrigo
- Boehringer Ingelheim
- Purdue Pharma
- C.B. Fleet
- Abbott
- Jiangzhong
- Xian-Janssen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastrointestinal Drugs, market overview.
Chapter 2: Global Gastrointestinal Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastrointestinal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastrointestinal Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Gastrointestinal Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 32740 million
|
| Forecast Market size by 2030 |
US$ 41410 million
|
| Growth Rate |
CAGR of 3.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Drugs Overall Market Size
2.1 Global Gastrointestinal Drugs Market Size: 2023 VS 2030
2.2 Global Gastrointestinal Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Gastrointestinal Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Gastrointestinal Drugs Players in Global Market
3.2 Top Global Gastrointestinal Drugs Companies Ranked by Revenue
3.3 Global Gastrointestinal Drugs Revenue by Companies
3.4 Global Gastrointestinal Drugs Sales by Companies
3.5 Global Gastrointestinal Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Gastrointestinal Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Gastrointestinal Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastrointestinal Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gastrointestinal Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastrointestinal Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Drugs Market Size Markets, 2023 & 2030
4.1.2 Prescription Gastrointestinal Drug
4.1.3 OTC Gastrointestinal Drug
4.2 By Type - Global Gastrointestinal Drugs Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Drugs Revenue, 2019-2024
4.2.2 By Type - Global Gastrointestinal Drugs Revenue, 2025-2030
4.2.3 By Type - Global Gastrointestinal Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Gastrointestinal Drugs Sales & Forecasts
4.3.1 By Type - Global Gastrointestinal Drugs Sales, 2019-2024
4.3.2 By Type - Global Gastrointestinal Drugs Sales, 2025-2030
4.3.3 By Type - Global Gastrointestinal Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Gastrointestinal Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Drugs Market Size, 2023 & 2030
5.1.2 Chronic Gastritis
5.1.3 Functional Dyspepsia
5.1.4 Peptic Ulcer
5.1.5 Acute Gastroenteritis
5.1.6 Other
5.2 By Application - Global Gastrointestinal Drugs Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Drugs Revenue, 2019-2024
5.2.2 By Application - Global Gastrointestinal Drugs Revenue, 2025-2030
5.2.3 By Application - Global Gastrointestinal Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Gastrointestinal Drugs Sales & Forecasts
5.3.1 By Application - Global Gastrointestinal Drugs Sales, 2019-2024
5.3.2 By Application - Global Gastrointestinal Drugs Sales, 2025-2030
5.3.3 By Application - Global Gastrointestinal Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Gastrointestinal Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Gastrointestinal Drugs Market Size, 2023 & 2030
6.2 By Region - Global Gastrointestinal Drugs Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Drugs Revenue, 2019-2024
6.2.2 By Region - Global Gastrointestinal Drugs Revenue, 2025-2030
6.2.3 By Region - Global Gastrointestinal Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Gastrointestinal Drugs Sales & Forecasts
6.3.1 By Region - Global Gastrointestinal Drugs Sales, 2019-2024
6.3.2 By Region - Global Gastrointestinal Drugs Sales, 2025-2030
6.3.3 By Region - Global Gastrointestinal Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Gastrointestinal Drugs Revenue, 2019-2030
6.4.2 By Country - North America Gastrointestinal Drugs Sales, 2019-2030
6.4.3 US Gastrointestinal Drugs Market Size, 2019-2030
6.4.4 Canada Gastrointestinal Drugs Market Size, 2019-2030
6.4.5 Mexico Gastrointestinal Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Gastrointestinal Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Gastrointestinal Drugs Sales, 2019-2030
6.5.3 Germany Gastrointestinal Drugs Market Size, 2019-2030
6.5.4 France Gastrointestinal Drugs Market Size, 2019-2030
6.5.5 U.K. Gastrointestinal Drugs Market Size, 2019-2030
6.5.6 Italy Gastrointestinal Drugs Market Size, 2019-2030
6.5.7 Russia Gastrointestinal Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Gastrointestinal Drugs Market Size, 2019-2030
6.5.9 Benelux Gastrointestinal Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Gastrointestinal Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Gastrointestinal Drugs Sales, 2019-2030
6.6.3 China Gastrointestinal Drugs Market Size, 2019-2030
6.6.4 Japan Gastrointestinal Drugs Market Size, 2019-2030
6.6.5 South Korea Gastrointestinal Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Gastrointestinal Drugs Market Size, 2019-2030
6.6.7 India Gastrointestinal Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Gastrointestinal Drugs Revenue, 2019-2030
6.7.2 By Country - South America Gastrointestinal Drugs Sales, 2019-2030
6.7.3 Brazil Gastrointestinal Drugs Market Size, 2019-2030
6.7.4 Argentina Gastrointestinal Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastrointestinal Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Gastrointestinal Drugs Sales, 2019-2030
6.8.3 Turkey Gastrointestinal Drugs Market Size, 2019-2030
6.8.4 Israel Gastrointestinal Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Gastrointestinal Drugs Market Size, 2019-2030
6.8.6 UAE Gastrointestinal Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Gastrointestinal Drugs Major Product Offerings
7.1.4 AstraZeneca Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Gastrointestinal Drugs Major Product Offerings
7.2.4 Sanofi Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Sanofi Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Gastrointestinal Drugs Major Product Offerings
7.3.4 Bayer Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Bayer Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Gastrointestinal Drugs Major Product Offerings
7.4.4 Pfizer Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Gastrointestinal Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Teva
7.6.1 Teva Company Summary
7.6.2 Teva Business Overview
7.6.3 Teva Gastrointestinal Drugs Major Product Offerings
7.6.4 Teva Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Teva Key News & Latest Developments
7.7 Zeria (Tillotts)
7.7.1 Zeria (Tillotts) Company Summary
7.7.2 Zeria (Tillotts) Business Overview
7.7.3 Zeria (Tillotts) Gastrointestinal Drugs Major Product Offerings
7.7.4 Zeria (Tillotts) Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Zeria (Tillotts) Key News & Latest Developments
7.8 Perrigo
7.8.1 Perrigo Company Summary
7.8.2 Perrigo Business Overview
7.8.3 Perrigo Gastrointestinal Drugs Major Product Offerings
7.8.4 Perrigo Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Perrigo Key News & Latest Developments
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Gastrointestinal Drugs Major Product Offerings
7.9.4 Boehringer Ingelheim Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Boehringer Ingelheim Key News & Latest Developments
7.10 Purdue Pharma
7.10.1 Purdue Pharma Company Summary
7.10.2 Purdue Pharma Business Overview
7.10.3 Purdue Pharma Gastrointestinal Drugs Major Product Offerings
7.10.4 Purdue Pharma Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Purdue Pharma Key News & Latest Developments
7.11 C.B. Fleet
7.11.1 C.B. Fleet Company Summary
7.11.2 C.B. Fleet Business Overview
7.11.3 C.B. Fleet Gastrointestinal Drugs Major Product Offerings
7.11.4 C.B. Fleet Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.11.5 C.B. Fleet Key News & Latest Developments
7.12 Abbott
7.12.1 Abbott Company Summary
7.12.2 Abbott Business Overview
7.12.3 Abbott Gastrointestinal Drugs Major Product Offerings
7.12.4 Abbott Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Abbott Key News & Latest Developments
7.13 Jiangzhong
7.13.1 Jiangzhong Company Summary
7.13.2 Jiangzhong Business Overview
7.13.3 Jiangzhong Gastrointestinal Drugs Major Product Offerings
7.13.4 Jiangzhong Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.13.5 Jiangzhong Key News & Latest Developments
7.14 Xian-Janssen
7.14.1 Xian-Janssen Company Summary
7.14.2 Xian-Janssen Business Overview
7.14.3 Xian-Janssen Gastrointestinal Drugs Major Product Offerings
7.14.4 Xian-Janssen Gastrointestinal Drugs Sales and Revenue in Global (2019-2024)
7.14.5 Xian-Janssen Key News & Latest Developments
8 Global Gastrointestinal Drugs Production Capacity, Analysis
8.1 Global Gastrointestinal Drugs Production Capacity, 2019-2030
8.2 Gastrointestinal Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastrointestinal Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastrointestinal Drugs Supply Chain Analysis
10.1 Gastrointestinal Drugs Industry Value Chain
10.2 Gastrointestinal Drugs Upstream Market
10.3 Gastrointestinal Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastrointestinal Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Gastrointestinal Drugs in Global Market
Table 2. Top Gastrointestinal Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Gastrointestinal Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Gastrointestinal Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Gastrointestinal Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global Gastrointestinal Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Gastrointestinal Drugs Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Gastrointestinal Drugs Product Type
Table 9. List of Global Tier 1 Gastrointestinal Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Gastrointestinal Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Gastrointestinal Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Gastrointestinal Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Gastrointestinal Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global Gastrointestinal Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global Gastrointestinal Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Gastrointestinal Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Gastrointestinal Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Gastrointestinal Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global Gastrointestinal Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Gastrointestinal Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Gastrointestinal Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Gastrointestinal Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Gastrointestinal Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global Gastrointestinal Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Gastrointestinal Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Gastrointestinal Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America Gastrointestinal Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Gastrointestinal Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Gastrointestinal Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe Gastrointestinal Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Gastrointestinal Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Gastrointestinal Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia Gastrointestinal Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Gastrointestinal Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Gastrointestinal Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America Gastrointestinal Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Gastrointestinal Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Gastrointestinal Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Gastrointestinal Drugs Sales, (K Units), 2025-2030
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Gastrointestinal Drugs Product Offerings
Table 48. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Gastrointestinal Drugs Product Offerings
Table 52. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Sanofi Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Gastrointestinal Drugs Product Offerings
Table 56. Bayer Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Bayer Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Gastrointestinal Drugs Product Offerings
Table 60. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Pfizer Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Gastrointestinal Drugs Product Offerings
Table 64. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Teva Company Summary
Table 67. Teva Gastrointestinal Drugs Product Offerings
Table 68. Teva Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Teva Key News & Latest Developments
Table 70. Zeria (Tillotts) Company Summary
Table 71. Zeria (Tillotts) Gastrointestinal Drugs Product Offerings
Table 72. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Zeria (Tillotts) Key News & Latest Developments
Table 74. Perrigo Company Summary
Table 75. Perrigo Gastrointestinal Drugs Product Offerings
Table 76. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Perrigo Key News & Latest Developments
Table 78. Boehringer Ingelheim Company Summary
Table 79. Boehringer Ingelheim Gastrointestinal Drugs Product Offerings
Table 80. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Boehringer Ingelheim Key News & Latest Developments
Table 82. Purdue Pharma Company Summary
Table 83. Purdue Pharma Gastrointestinal Drugs Product Offerings
Table 84. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Purdue Pharma Key News & Latest Developments
Table 86. C.B. Fleet Company Summary
Table 87. C.B. Fleet Gastrointestinal Drugs Product Offerings
Table 88. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 89. C.B. Fleet Key News & Latest Developments
Table 90. Abbott Company Summary
Table 91. Abbott Gastrointestinal Drugs Product Offerings
Table 92. Abbott Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 93. Abbott Key News & Latest Developments
Table 94. Jiangzhong Company Summary
Table 95. Jiangzhong Gastrointestinal Drugs Product Offerings
Table 96. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 97. Jiangzhong Key News & Latest Developments
Table 98. Xian-Janssen Company Summary
Table 99. Xian-Janssen Gastrointestinal Drugs Product Offerings
Table 100. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 101. Xian-Janssen Key News & Latest Developments
Table 102. Gastrointestinal Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 103. Global Gastrointestinal Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 104. Global Gastrointestinal Drugs Production by Region, 2019-2024 (K Units)
Table 105. Global Gastrointestinal Drugs Production by Region, 2025-2030 (K Units)
Table 106. Gastrointestinal Drugs Market Opportunities & Trends in Global Market
Table 107. Gastrointestinal Drugs Market Drivers in Global Market
Table 108. Gastrointestinal Drugs Market Restraints in Global Market
Table 109. Gastrointestinal Drugs Raw Materials
Table 110. Gastrointestinal Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Gastrointestinal Drugs Downstream
Table 112. Gastrointestinal Drugs Downstream Clients in Global Market
Table 113. Gastrointestinal Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastrointestinal Drugs Segment by Type in 2023
Figure 2. Gastrointestinal Drugs Segment by Application in 2023
Figure 3. Global Gastrointestinal Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Gastrointestinal Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Gastrointestinal Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gastrointestinal Drugs Revenue in 2023
Figure 9. By Type - Global Gastrointestinal Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Gastrointestinal Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Gastrointestinal Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Gastrointestinal Drugs Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Gastrointestinal Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Gastrointestinal Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Gastrointestinal Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Gastrointestinal Drugs Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Gastrointestinal Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Gastrointestinal Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Gastrointestinal Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Gastrointestinal Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Gastrointestinal Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Gastrointestinal Drugs Sales Market Share, 2019-2030
Figure 23. US Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Gastrointestinal Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Gastrointestinal Drugs Sales Market Share, 2019-2030
Figure 28. Germany Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Gastrointestinal Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Gastrointestinal Drugs Sales Market Share, 2019-2030
Figure 37. China Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Gastrointestinal Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Gastrointestinal Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Gastrointestinal Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Gastrointestinal Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Gastrointestinal Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Gastrointestinal Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Gastrointestinal Drugs by Region, 2023 VS 2030
Figure 54. Gastrointestinal Drugs Industry Value Chain
Figure 55. Marketing Channels
